{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T11:05:45Z","timestamp":1779879945825,"version":"3.53.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T00:00:00Z","timestamp":1540166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS091165"],"award-info":[{"award-number":["NS091165"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS099460"],"award-info":[{"award-number":["NS099460"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS076759"],"award-info":[{"award-number":["NS076759"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4874-8","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:55:26Z","timestamp":1540227326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Kr\u00fcppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells"],"prefix":"10.1186","volume":"18","author":[{"given":"Brian","family":"Tung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olutobi","family":"Oyinlade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Laterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Qing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5849-6967","authenticated-orcid":false,"given":"Shuli","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,22]]},"reference":[{"key":"4874_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-med-100711-143028","volume":"64","author":"JT Huse","year":"2013","unstructured":"Huse JT, Holland E, DeAngelis LM. Glioblastoma: molecular analysis and clinical implications. Annu Rev Med. 2013;64:59\u201370.","journal-title":"Annu Rev Med"},{"key":"4874_CR2","first-page":"76","volume":"3","author":"H Enderling","year":"2013","unstructured":"Enderling H, Hlatky L, Hahnfeldt P. Cancer stem cells: a minor Cancer subpopulation that redefines global Cancer features. Front Oncol. 2013;3:76.","journal-title":"Front Oncol"},{"key":"4874_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2217\/cns.13.23","volume":"2","author":"JS Hale","year":"2013","unstructured":"Hale JS, Sinyuk M, Rich JN, Lathia JD. Decoding the cancer stem cell hypothesis in glioblastoma. CNS Oncol. 2013;2:319\u201330.","journal-title":"CNS Oncol"},{"key":"4874_CR4","doi-asserted-by":"crossref","unstructured":"Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Curr Protoc Pharmacol, 2013; Chapter 14: Unit 14 25.","DOI":"10.1002\/0471141755.ph1425s61"},{"key":"4874_CR5","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","volume":"64","author":"R Galli","year":"2004","unstructured":"Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64:7011\u201321.","journal-title":"Cancer Res"},{"key":"4874_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444:761\u20135.","journal-title":"Nature"},{"key":"4874_CR7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/stem.89","volume":"27","author":"P Sun","year":"2009","unstructured":"Sun P, Xia S, Lal B, et al. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells. 2009;27:1473\u201386.","journal-title":"Stem Cells"},{"key":"4874_CR8","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1038\/onc.2011.58","volume":"30","author":"M Ying","year":"2011","unstructured":"Ying M, Wang S, Sang Y, et al. Regulation of glioblastoma stem cells by retinoic acid: role for notch pathway inhibition. Oncogene. 2011;30:3454\u201367.","journal-title":"Oncogene"},{"key":"4874_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/stem.561","volume":"29","author":"M Ying","year":"2011","unstructured":"Ying M, Sang Y, Li Y, et al. Kruppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells. 2011;29:20\u201331.","journal-title":"Stem Cells"},{"key":"4874_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/gb-2003-4-2-206","volume":"4","author":"J Kaczynski","year":"2003","unstructured":"Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4:206.","journal-title":"Genome Biol"},{"key":"4874_CR11","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.biocel.2007.07.018","volume":"40","author":"R Pearson","year":"2008","unstructured":"Pearson R, Fleetwood J, Eaton S, Crossley M, Bao S. Kruppel-like transcription factors: a functional family. Int J Biochem Cell Biol. 2008;40:1996\u20132001.","journal-title":"Int J Biochem Cell Biol"},{"key":"4874_CR12","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1074\/jbc.RA117.001323","volume":"293","author":"S Wang","year":"2018","unstructured":"Wang S, Shi X, Wei S, et al. Kruppel-like factor 4 (KLF4) induces mitochondrial fusion and increases spare respiratory capacity of human glioblastoma cells. J Biol Chem. 2018;293:6544\u201355.","journal-title":"J Biol Chem"},{"key":"4874_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056082","volume":"8","author":"Z Leng","year":"2013","unstructured":"Leng Z, Tao K, Xia Q, et al. Kruppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLoS One. 2013;8:e56082.","journal-title":"PLoS One"},{"key":"4874_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043593","volume":"7","author":"ZS Lin","year":"2012","unstructured":"Lin ZS, Chu HC, Yen YC, Lewis BC, Chen YW. Kruppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS One. 2012;7:e43593.","journal-title":"PLoS One"},{"key":"4874_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1440-1827.2008.02233.x","volume":"58","author":"L Kang","year":"2008","unstructured":"Kang L, Lu B, Xu J, Hu H, Lai M. Downregulation of Kruppel-like factor 9 in human colorectal cancer. Pathol Int. 2008;58:334\u20138.","journal-title":"Pathol Int"},{"key":"4874_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1477-7827-6-41","volume":"6","author":"FA Simmen","year":"2008","unstructured":"Simmen FA, Su Y, Xiao R, Zeng Z, Simmen RC. The Kruppel-like factor 9 (KLF9) network in HEC-1-a endometrial carcinoma cells suggests the carcinogenic potential of dys-regulated KLF9 expression. Reprod Biol Endocrinol. 2008;6:41.","journal-title":"Reprod Biol Endocrinol"},{"key":"4874_CR17","doi-asserted-by":"publisher","first-page":"32742","DOI":"10.1074\/jbc.M114.588988","volume":"289","author":"M Ying","year":"2014","unstructured":"Ying M, Tilghman J, Wei Y, et al. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin alpha6 inhibition. J Biol Chem. 2014;289:32742\u201356.","journal-title":"J Biol Chem"},{"key":"4874_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","volume":"81","author":"R Kanwal","year":"2012","unstructured":"Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet. 2012;81:303\u201311.","journal-title":"Clin Genet"},{"key":"4874_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13148-010-0006-2","volume":"1","author":"FP Tambaro","year":"2010","unstructured":"Tambaro FP, Dell\u2019aversana C, Carafa V, et al. Histone deacetylase inhibitors: clinical implications for hematological malignancies. Clin Epigenetics. 2010;1:25\u201344.","journal-title":"Clin Epigenetics"},{"key":"4874_CR20","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3892\/ijo.2012.1551","volume":"41","author":"D Bellarosa","year":"2012","unstructured":"Bellarosa D, Bressan A, Bigioni M, et al. SAHA\/Vorinostat induces the expression of the CD137 receptor\/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line. Int J Oncol. 2012;41:1486\u201394.","journal-title":"Int J Oncol"},{"key":"4874_CR21","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1016\/j.celrep.2016.08.005","volume":"16","author":"V Gaur","year":"2016","unstructured":"Gaur V, Connor T, Sanigorski A, et al. Disruption of the class IIa HDAC corepressor complex increases energy expenditure and lipid oxidation. Cell Rep. 2016;16:2802\u201310.","journal-title":"Cell Rep"},{"key":"4874_CR22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/mol.105.017145","volume":"69","author":"RR Rosato","year":"2006","unstructured":"Rosato RR, Maggio SC, Almenara JA, et al. The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide. Mol Pharmacol. 2006;69:216\u201325.","journal-title":"Mol Pharmacol"},{"key":"4874_CR23","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1158\/1078-0432.CCR-15-0530","volume":"21","author":"JP Laubach","year":"2015","unstructured":"Laubach JP, Moreau P, San-Miguel JF, Richardson PG. Panobinostat for the treatment of multiple myeloma. Clin Cancer Res. 2015;21:4767\u201373.","journal-title":"Clin Cancer Res"},{"key":"4874_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/1471-2407-14-401","volume":"14","author":"P Sun","year":"2014","unstructured":"Sun P, Xia S, Lal B, et al. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity. BMC Cancer. 2014;14:401.","journal-title":"BMC Cancer"},{"key":"4874_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/CAD.0b013e3283484750","volume":"22","author":"CR Goodwin","year":"2011","unstructured":"Goodwin CR, Lal B, Ho S, et al. PTEN reconstitution alters glioma responses to c-met pathway inhibition. Anti-Cancer Drugs. 2011;22:905\u201312.","journal-title":"Anti-Cancer Drugs"},{"key":"4874_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072671","volume":"8","author":"CL Woodard","year":"2013","unstructured":"Woodard CL, Goodwin CR, Wan J, et al. Profiling the dynamics of a human phosphorylome reveals new components in HGF\/c-met signaling. PLoS One. 2013;8:e72671.","journal-title":"PLoS One"},{"key":"4874_CR27","doi-asserted-by":"crossref","unstructured":"Wan J, Su Y, Song Q, et al. Methylated cis-regulatory elements mediate KLF4-dependent gene transactivation and cell migration. Elife. 2017:6.","DOI":"10.7554\/eLife.20068"},{"key":"4874_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ijc.20754","volume":"115","author":"JA Menendez","year":"2005","unstructured":"Menendez JA, Vellon L, Colomer R, Lupu R. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Int J Cancer. 2005;115:19\u201335.","journal-title":"Int J Cancer"},{"key":"4874_CR29","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1038\/s41388-018-0138-y","volume":"37","author":"O Oyinlade","year":"2018","unstructured":"Oyinlade O, Wei S, Lal B, et al. Targeting UDP-alpha-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration. Oncogene. 2018;37:2615\u201329.","journal-title":"Oncogene"},{"key":"4874_CR30","doi-asserted-by":"crossref","unstructured":"Wei S, Wang J, Oyinlade O, et al. Heterozygous IDH1 (R132H\/WT) created by \u201csingle base editing\u201d inhibits human astroglial cell growth by downregulating YAP. Oncogene. 2018.","DOI":"10.1158\/1538-7445.AM2018-531"},{"key":"4874_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2407-8-325","volume":"8","author":"Y Li","year":"2008","unstructured":"Li Y, Fan X, Goodwin CR, Laterra J, Xia S. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5. BMC Cancer. 2008;8:325.","journal-title":"BMC Cancer"},{"key":"4874_CR32","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbrc.2006.05.064","volume":"345","author":"S Xia","year":"2006","unstructured":"Xia S, Laterra J. Hepatocyte growth factor increases mitochondrial mass in glioblastoma cells. Biochem Biophys Res Commun. 2006;345:1358\u201364.","journal-title":"Biochem Biophys Res Commun"},{"key":"4874_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neo.2016.02.003","volume":"18","author":"J Tilghman","year":"2016","unstructured":"Tilghman J, Schiapparelli P, Lal B, et al. Regulation of glioblastoma tumor-propagating cells by the integrin partner Tetraspanin CD151. Neoplasia. 2016;18:185\u201398.","journal-title":"Neoplasia"},{"key":"4874_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1349-7006.2012.02260.x","volume":"103","author":"Y Wu","year":"2012","unstructured":"Wu Y, Richard JP, Wang SD, et al. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors. Cancer Sci. 2012;103:1028\u201337.","journal-title":"Cancer Sci"},{"key":"4874_CR35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/CAD.0b013e32832fe472","volume":"20","author":"Y Li","year":"2009","unstructured":"Li Y, Rory Goodwin C, Sang Y, et al. Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms. Anti-Cancer Drugs. 2009;20:770\u20138.","journal-title":"Anti-Cancer Drugs"},{"key":"4874_CR36","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.stem.2009.03.014","volume":"4","author":"SM Pollard","year":"2009","unstructured":"Pollard SM, Yoshikawa K, Clarke ID, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell. 2009;4:568\u201380.","journal-title":"Cell Stem Cell"},{"key":"4874_CR37","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1158\/0008-5472.CAN-15-1626","volume":"75","author":"IA Chatzispyrou","year":"2015","unstructured":"Chatzispyrou IA, Held NM, Mouchiroud L, Auwerx J, Houtkooper RH. Tetracycline antibiotics impair mitochondrial function and its experimental use confounds research. Cancer Res. 2015;75:4446\u20139.","journal-title":"Cancer Res"},{"key":"4874_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1158\/1541-7786.MCR-06-0433","volume":"5","author":"S Xia","year":"2007","unstructured":"Xia S, Li Y, Rosen EM, Laterra J. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim. Mol Cancer Res. 2007;5:783\u201392.","journal-title":"Mol Cancer Res"},{"key":"4874_CR39","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1002\/jcb.24491","volume":"114","author":"H Jin","year":"2013","unstructured":"Jin H, Liang L, Liu L, Deng W, Liu J. HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells. J Cell Biochem. 2013;114:1498\u2013509.","journal-title":"J Cell Biochem"},{"key":"4874_CR40","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","volume":"23","author":"M Castedo","year":"2004","unstructured":"Castedo M, Perfettini JL, Roumier T, et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene. 2004;23:2825\u201337.","journal-title":"Oncogene"},{"key":"4874_CR41","doi-asserted-by":"publisher","first-page":"e1435","DOI":"10.1038\/cddis.2014.412","volume":"5","author":"M Cornago","year":"2014","unstructured":"Cornago M, Garcia-Alberich C, Blasco-Angulo N, et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis. 2014;5:e1435.","journal-title":"Cell Death Dis"},{"key":"4874_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517:311\u201320.","journal-title":"Nature"},{"key":"4874_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/cdd.2010.72","volume":"18","author":"YT Wu","year":"2011","unstructured":"Wu YT, Tan HL, Huang Q, et al. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ. 2011;18:26\u201337.","journal-title":"Cell Death Differ"},{"key":"4874_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1:112\u20139.","journal-title":"Nat Chem Biol"},{"key":"4874_CR45","doi-asserted-by":"crossref","first-page":"86726","DOI":"10.18632\/oncotarget.21418","volume":"8","author":"W Dong","year":"2017","unstructured":"Dong W, Zhang M, Zhu Y, et al. Protective effect of NSA on intestinal epithelial cells in a necroptosis model. Oncotarget. 2017;8:86726\u201335.","journal-title":"Oncotarget"},{"key":"4874_CR46","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni.3206","volume":"16","author":"J Silke","year":"2015","unstructured":"Silke J, Rickard JA, Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015;16:689\u201397.","journal-title":"Nat Immunol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4874-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4874-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4874-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T13:29:47Z","timestamp":1589462987000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4874-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,22]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4874"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4874-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,22]]},"assertion":[{"value":"1 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study uses cell lines derived from surgical wastes therefore no ethics approval is required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1025"}}